© 2024 Leadoptik, Inc.,All Rights Reserved.
.svg)
.png){kind=small}
Our flagship LIA™ Technology immediately advances clinical capabilities for pulmonary imaging and biopsy.
OPTICS FOR CANCER DETECTION
We are on a mission to to improve patient lives through early lung cancer detection.
optics for cancer detection
We are on a mission to to improve patient lives through early lung cancer detection.
OPTICS FOR CANCER DETECTION
We are on a mission to to improve patient lives through early lung cancer detection.
OPTICS FOR CANCER DETECTION
We are on a mission to to improve patient lives through early lung cancer detection.
“Despite significant advancements in interventional pulmonology, confirming the placement of a biopsy needle in small lesions remains challenging. However, I am very optimistic about the early results from LIA and its real-time nodule assessment capabilities. I believe this willsubstantially narrow the knowledge gap.”
“It's an exciting time for Interventional Pulmonology as we embrace LIA's pioneering microstructure imaging technology. This innovation is the key to unlocking unprecedented precision in IP biopsies, enriching our clinical acumen. I'm enthused by the potential of LIA to refine patient care and eager to contribute to the groundbreaking work that willshape the future of our field.”
“Real-time microstructure imaging to guide biopsy has been something missing in IP. LEADOPTIK technology will demonstrate the clinical utility of their product for everyday use in the bronch suite. I am very excited by their approach and the evaluation of quality, cost, and usefulness as they arepreparing for their FDA submission.”
OPTICS FOR CANCER DETECTION
We are on a mission to to improve patient lives through early lung cancer detection.
© 2024 Leadoptik, Inc.,All Rights Reserved.